T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Live Oak Bancshares
LOB
$1.98B
| $1.18M | ﹤0.01% |
24,843
+1,214
| +5% | +$50.8K |
|
1902
Navient
NAVI
$829M
| $1.17M | ﹤0.01% |
75,145
-3,560
| -5% | -$54.8K |
|
|
PDCO
1903
DELISTED
Patterson Companies, Inc.
PDCO
| $1.16M | ﹤0.01% |
53,231
+637
| +1% | +$15.1K |
|
1904
NCR Atleos
NATL
$3.47B
| $1.16M | ﹤0.01% |
40,589
+667
| +2% | +$19.4K |
|
1905
Privia Health
PRVA
$2.75B
| $1.16M | ﹤0.01% |
63,536
+1,429
| +2% | +$27.3K |
|
|
CSGS
1906
DELISTED
CSG Systems International
CSGS
| $1.16M | ﹤0.01% |
23,758
+281
| +1% | +$12.8K |
|
1907
Woodside Energy
WDS
$43.6B
| $1.16M | ﹤0.01% |
67,000
-6,362
| -9% | -$113K |
|
|
SAFE
1908
Safehold
SAFE
$1.09B
| $1.15M | ﹤0.01% |
43,885
-400
| -0.9% | -$9.44K |
|
|
STR
1909
DELISTED
Sitio Royalties
STR
| $1.15M | ﹤0.01% |
55,007
+1,770
| +3% | +$40.1K |
|
1910
ADT
ADT
$5.34B
| $1.15M | ﹤0.01% |
158,434
+14,198
| +10% | +$104K |
|
1911
Hawaiian Electric Industries
HE
$2.06B
| $1.14M | ﹤0.01% |
117,975
+18,747
| +19% | +$232K |
|
1912
Stepan Co
SCL
$1.48B
| $1.14M | ﹤0.01% |
14,781
+193
| +1% | +$15.3K |
|
1913
Novavax
NVAX
$1.34B
| $1.14M | ﹤0.01% |
90,223
+17,667
| +24% | +$228K |
|
|
GTY
1914
Getty Realty Corp
GTY
$2.04B
| $1.14M | ﹤0.01% |
35,764
+428
| +1% | +$13.1K |
|
|
AMWD
1915
DELISTED
American Woodmark
AMWD
| $1.13M | ﹤0.01% |
12,128
-81
| -0.7% | -$7.29K |
|
1916
Chewy
CHWY
$9.15B
| $1.13M | ﹤0.01% |
38,668
+3,041
| +9% | +$81.1K |
|
1917
AtriCure
ATRC
$2.22B
| $1.13M | ﹤0.01% |
40,329
+471
| +1% | +$11.6K |
|
1918
Leggett & Platt
LEG
$1.29B
| $1.13M | ﹤0.01% |
82,921
+7,838
| +10% | +$97.9K |
|
1919
StoneCo
STNE
$2.49B
| $1.13M | ﹤0.01% |
100,167
+9,232
| +10% | +$118K |
|
1920
Cable One
CABO
$191M
| $1.13M | ﹤0.01% |
3,221
+166
| +5% | +$59.4K |
|
1921
Teladoc Health
TDOC
$1.26B
| $1.13M | ﹤0.01% |
122,734
+22,605
| +23% | +$187K |
|
|
CIM
1922
Chimera Investment
CIM
$991M
| $1.13M | ﹤0.01% |
71,108
+784
| +1% | +$11.7K |
|
1923
Lakeland Financial Corp
LKFN
$1.55B
| $1.13M | ﹤0.01% |
17,289
+221
| +1% | +$14.4K |
|
1924
CRISPR Therapeutics
CRSP
$5.22B
| $1.12M | ﹤0.01% |
23,763
-396,932
| -94% | -$20.1M |
|
|
MFA
1925
MFA Financial
MFA
$925M
| $1.11M | ﹤0.01% |
87,198
+998
| +1% | +$11.8K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.